This page is the continuation of reference in support of Section 4d.
REFERENCES
American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th edition, Edge, S.B., Byrd, D.R., Compton, C.C., et al (Eds), Springer, New York 2010.
Bernstein, L. The epidemiology of breast carcinoma in situ. In: Silverstein ML, editor. Ductal Carcinoma In Situ of the Breast. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002.
Bijker, N., Meijnen, P., Peterse, J.L., et al. (2006). Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III Trial 10853—A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16801628
Chuba, P.J., Hamre, M.R., Yap, J., Severson, R.K., Lucas, D., Shamsa, F., Aref, A. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 2005;23(24):5534. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16110014
Bradley, S.J., Weaver, D.W., Bowman, D.L. (1990). Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome.
Am J Surg. 1990;56(7):428. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/2164336
Collins, L.C., Baer, H.J., Tamimi, R.M., Connolly, J.L., Colditz, G.A., Schnitt, S.J. (2007). Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer 109(2), 180. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/17154175
Darby, S.C., McGale, P., Taylor, C.W., et al. (2005). Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557-565. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16054566
Dupont, W.D., Page, D.L. (1985). Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3), 146-151. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/3965932
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). (2005). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366, 2087-2106. (Retrieved November 6th 2014): https://www.sciencedirect.com/science/article/pii/S0140673605678877
Fisher, E.R., Dignam, J., Tan-Chiu, E., Costantino, J., Fisher, B., Paik, S., Wolmark, N. (1999). Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86(3), 429. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed?term=10430251
Fisher, E.R., Land, S.R., Fisher, B., Mamounas, E., Gilarski, L., Wolmark, N. (2004). Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004;100(2):238. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/14716756
Fitzgibbons, P.L., Henson, D.E., Hutter, R.V.P. (1998). Benign breast changes and the risk for subsequent breast cancer – An update of the 1985 consensus statement. Arch Pathol Lab Med. 122, 1053–1055. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/9870852
Marshall, L.M>, Hunter, D.J., Connolly, J.L., Schnitt, S.J., Byrne, C., London, S.J., Colditz, G.A. (1997). Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. May;6(5):297-301. (Retrieved January 12th 2014) http://www.ncbi.nlm.nih.gov/pubmed/9149887
Hughes, L.L., Wang, M., Page, D.L., Gray, R., Solin, L.J., Davidson, N.E., Lowen, M.A., Ingle, J.N., Recht, A., Wood, W.C. (2009). Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27(32), 5319. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773217/
King, T.A., Muhsen, S., Patil, S., Koslow, S., Oskar, S., Park, A., Morrogh, M., Sakr, R.A., Morrow, M. (2013). Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat. 142(2), 445-53. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871867/
Lakhani, S., Ellis, I., Schnitt, S., et al. (2012). WHO Classification of Tumours of the Breast, 4th ed. Lyon, IARC Press. (Retrieved November 6th 2014): http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4004
National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. Retrieved November 6th 2014): http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Page DL, Anderson TJ. Diagnostic Histopathology of the Breast, Churchill Livingstone, Edinburgh 1987.
Page, D.L., Salhany, K.E., Jensen, R.A., et al. (1996). Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 78:258-266. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8674001
Page, D.L., Schuyler, P.A., Dupont, W.D., Jensen, R.A., Plummer,W.D. Jr, Simpson, J.F. (2003). Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361(9352), 125. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/12531579
Pradier, C., Cornuau, M., Norca, J., Mesbah, H., Poree, P., Body, G., Classe, J-M, Leveque, J. (2011). Differences in Breast Carcinoma In Situ Between Menopausal and Premenopausal Women. Anticancer Res 31 (5), 1783-1788. (Retrieved November 6th 2014): http://ar.iiarjournals.org/search?author1=PHILIPPE+POREE&sortspec=date&submit=Submit
Rosen, P.P., Oberman, H. Tumors of the Mammary Gland, Armed Forces Institute of Pathology, Washington, DC 1993.
Schairer, C., Mink, P.J., Carroll, L., et al. (2004). Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96, 1311-1321. (Retrieved November 6th 2014): https://academic.oup.com/jnci/article/96/17/1311/2520929
Schonberg, M.A., Marcantonio, E.R., Ngo, L., Li, D., Silliman, R.A., McCarthy, E.P. (2011). Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol 29(12), 1570. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/21402602
Schwartz, T., Cyr, A., Margenthaler, J. (2014). Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res S0022-4804. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/25277350
Silverstein, M.J., Waisman, J.R., Gamagami, P. et al. (1990). Intraduect carcinoma of the breast (208 cases). Clinical factors influencing treatment choice. Cancer 66, 102. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/2162238
Silverstein, M.J., Lagios, M.D., Craig, P.H., Waisman, J.R., Lewinsky, B.S., Colburn, W.J., Poller, D.N. (1996). A prognostic index for ductal carcinoma in situ of the breast. Cancer 77(11), 2267. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8635094
Simpson, J.L., Page, D.L. (1996). The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancer. Semin Oncol. 23(4), 428-35. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8757269
Simpson, P.T., Gale, T., Reis-Filho, J.S. et al. (2005). Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29(6), 734-46. (Retrieved November 6th 2014): http://www.ncbi.nlm.nih.gov/pubmed/15897740
Sinn, H-P., Kreipe, H. (2013). A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. Breast Care (Basel). May 2013; 8(2): 149–154. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683948/
Solin, L.J., Fourquet, A., Vicini, F.A. et al. (2005). Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103(6), 1137. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/15674853
Staley, H., McCallum, I., Bruce, J. (2012). Postoperative tamoxifen for ductal carcinoma in situ. Cochrane Database Syst Rev 10, CD007847. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/23076938
Tavassoli FA, Devilee P (eds): Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, IARC Press, 2003.
Tromberg, B.J., Natasha, S., Lanning, R., Cerussi, A., Espinoza, J., Pham, T., Svaasand, L., Butler, J.(2000)Non-Invasive In Vivo Characterization of Breast Tumors Using Photon Migration Spectroscopy. Neoplasia
Volume 2, Issues 1–2, January–April 2000, Pages 26–40 (Retrieved January 11th 2014):http://www.sciencedirect.com/science/article/pii/S1476558600800184
